Bio-Techne Corp
(STU:TE1)
€
69.5
0 (0%)
Market Cap: 11.07 Bil
Enterprise Value: 11.27 Bil
PE Ratio: 80.74
PB Ratio: 5.63
GF Score: 95/100 
Bio-Techne Corp at Evercore HealthCONx Conference Transcript
Dec 04, 2019 / 04:45PM GMT
Release Date Price:
€49
(+1.03%)
Luke England Sergott
Evercore ISI Institutional Equities, Research Division - Associate
All right. Okay. I guess we'll get started. I'm Luke Sergott. I cover the life sciences diagnostic tools here. I have the pleasure to be here with Chuck Kummeth of Bio-Techne. He's been there, 7 years you were just saying?
Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director
Almost -- 7 in April.
Luke England Sergott
Evercore ISI Institutional Equities, Research Division - Associate
Almost 7 years running one of the best premier tools companies out there.
Questions & Answers
Luke England Sergott
Evercore ISI Institutional Equities, Research Division - Associate
So I guess, we can just kind of dive in. And I mean, as you look at the company today, and as you have been a consolidator, kind of walk us through the overall strategy. And if you look at some of those businesses that you have in the portfolio, some of them in more mature markets, some in the
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers